{
  "success": true,
  "pagesUsed": [
    3,
    6,
    8
  ],
  "modelUsed": "gemini-2.5-pro",
  "narrative": {
    "narrativeContents": [
      {
        "id": "nc_1",
        "name": "PROTOCOL SUMMARY",
        "order": 0,
        "instanceType": "NarrativeContent",
        "sectionNumber": "1",
        "sectionTitle": "PROTOCOL SUMMARY",
        "sectionType": {
          "code": "Synopsis",
          "codeSystem": "USDM",
          "decode": "Synopsis"
        },
        "childIds": [
          "nci_1_1",
          "nci_1_2",
          "nci_1_3"
        ]
      },
      {
        "id": "nc_2",
        "name": "INTRODUCTION",
        "order": 1,
        "instanceType": "NarrativeContent",
        "sectionNumber": "2",
        "sectionTitle": "INTRODUCTION",
        "sectionType": {
          "code": "Introduction",
          "codeSystem": "USDM",
          "decode": "Introduction"
        },
        "childIds": [
          "nci_2_1",
          "nci_2_2",
          "nci_2_3"
        ]
      },
      {
        "id": "nc_3",
        "name": "OBJECTIVES AND ENDPOINTS",
        "order": 2,
        "instanceType": "NarrativeContent",
        "sectionNumber": "3",
        "sectionTitle": "OBJECTIVES AND ENDPOINTS",
        "sectionType": {
          "code": "Objectives",
          "codeSystem": "USDM",
          "decode": "Objectives"
        }
      },
      {
        "id": "nc_4",
        "name": "STUDY DESIGN",
        "order": 3,
        "instanceType": "NarrativeContent",
        "sectionNumber": "4",
        "sectionTitle": "STUDY DESIGN",
        "sectionType": {
          "code": "Study Design",
          "codeSystem": "USDM",
          "decode": "Study Design"
        },
        "childIds": [
          "nci_4_1",
          "nci_4_2",
          "nci_4_3",
          "nci_4_4"
        ]
      },
      {
        "id": "nc_5",
        "name": "STUDY POPULATION",
        "order": 4,
        "instanceType": "NarrativeContent",
        "sectionNumber": "5",
        "sectionTitle": "STUDY POPULATION",
        "sectionType": {
          "code": "Study Population",
          "codeSystem": "USDM",
          "decode": "Study Population"
        },
        "childIds": [
          "nci_5_1",
          "nci_5_2",
          "nci_5_3",
          "nci_5_4"
        ]
      },
      {
        "id": "nc_6",
        "name": "STUDY INTERVENTION",
        "order": 5,
        "instanceType": "NarrativeContent",
        "sectionNumber": "6",
        "sectionTitle": "STUDY INTERVENTION",
        "sectionType": {
          "code": "Treatment",
          "codeSystem": "USDM",
          "decode": "Treatment"
        }
      },
      {
        "id": "nc_7",
        "name": "Study and Site Start and Closure",
        "order": 6,
        "instanceType": "NarrativeContent",
        "sectionNumber": "10.1.8",
        "sectionTitle": "Study and Site Start and Closure",
        "sectionType": {
          "code": "Other",
          "codeSystem": "USDM",
          "decode": "Other"
        }
      },
      {
        "id": "nc_8",
        "name": "Publication Policy",
        "order": 7,
        "instanceType": "NarrativeContent",
        "sectionNumber": "10.1.9",
        "sectionTitle": "Publication Policy",
        "sectionType": {
          "code": "Ethics",
          "codeSystem": "USDM",
          "decode": "Ethics"
        }
      },
      {
        "id": "nc_9",
        "name": "Clinical Laboratory Tests",
        "order": 8,
        "instanceType": "NarrativeContent",
        "sectionNumber": "10.2",
        "sectionTitle": "Clinical Laboratory Tests",
        "sectionType": {
          "code": "Assessments",
          "codeSystem": "USDM",
          "decode": "Assessments"
        }
      },
      {
        "id": "nc_10",
        "name": "Adverse Events: Definitions and Procedures for Recording, Evaluating, Follow-up, and Reporting",
        "order": 9,
        "instanceType": "NarrativeContent",
        "sectionNumber": "10.3",
        "sectionTitle": "Adverse Events: Definitions and Procedures for Recording, Evaluating, Follow-up, and Reporting",
        "sectionType": {
          "code": "Safety",
          "codeSystem": "USDM",
          "decode": "Safety"
        },
        "childIds": [
          "nci_10_1",
          "nci_10_2",
          "nci_10_3",
          "nci_10_4"
        ]
      },
      {
        "id": "nc_11",
        "name": "Contraceptive Guidance and Collection of Pregnancy Information",
        "order": 10,
        "instanceType": "NarrativeContent",
        "sectionNumber": "10.4",
        "sectionTitle": "Contraceptive Guidance and Collection of Pregnancy Information",
        "sectionType": {
          "code": "Safety",
          "codeSystem": "USDM",
          "decode": "Safety"
        },
        "childIds": [
          "nci_11_1",
          "nci_11_2"
        ]
      },
      {
        "id": "nc_12",
        "name": "COVID-19 Vaccine Risk Assessment",
        "order": 11,
        "instanceType": "NarrativeContent",
        "sectionNumber": "10.5",
        "sectionTitle": "COVID-19 Vaccine Risk Assessment",
        "sectionType": {
          "code": "Safety",
          "codeSystem": "USDM",
          "decode": "Safety"
        }
      },
      {
        "id": "nc_13",
        "name": "Abbreviations",
        "order": 12,
        "instanceType": "NarrativeContent",
        "sectionNumber": "10.6",
        "sectionTitle": "Abbreviations",
        "sectionType": {
          "code": "Appendix",
          "codeSystem": "USDM",
          "decode": "Appendix"
        }
      },
      {
        "id": "nc_14",
        "name": "Protocol Amendment History",
        "order": 13,
        "instanceType": "NarrativeContent",
        "sectionNumber": "10.7",
        "sectionTitle": "Protocol Amendment History",
        "sectionType": {
          "code": "Other",
          "codeSystem": "USDM",
          "decode": "Other"
        }
      },
      {
        "id": "nc_15",
        "name": "REFERENCES",
        "order": 14,
        "instanceType": "NarrativeContent",
        "sectionNumber": "11",
        "sectionTitle": "REFERENCES",
        "sectionType": {
          "code": "References",
          "codeSystem": "USDM",
          "decode": "References"
        }
      }
    ],
    "narrativeContentItems": [
      {
        "id": "nci_1_1",
        "name": "Synopsis",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.1",
        "sectionTitle": "Synopsis"
      },
      {
        "id": "nci_1_2",
        "name": "Schema",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.2",
        "sectionTitle": "Schema"
      },
      {
        "id": "nci_1_3",
        "name": "Schedule of Activities (SoA)",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.3",
        "sectionTitle": "Schedule of Activities (SoA)"
      },
      {
        "id": "nci_2_1",
        "name": "Study Rationale",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.1",
        "sectionTitle": "Study Rationale"
      },
      {
        "id": "nci_2_2",
        "name": "Background",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.2",
        "sectionTitle": "Background"
      },
      {
        "id": "nci_2_3",
        "name": "Benefit-Risk Assessment",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.3",
        "sectionTitle": "Benefit-Risk Assessment"
      },
      {
        "id": "nci_4_1",
        "name": "Overall Design",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "4.1",
        "sectionTitle": "Overall Design"
      },
      {
        "id": "nci_4_2",
        "name": "Scientific Rationale for Study Design",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "4.2",
        "sectionTitle": "Scientific Rationale for Study Design"
      },
      {
        "id": "nci_4_3",
        "name": "Justification for Dose",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "4.3",
        "sectionTitle": "Justification for Dose"
      },
      {
        "id": "nci_4_4",
        "name": "End of Study Definition",
        "text": "",
        "order": 3,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "4.4",
        "sectionTitle": "End of Study Definition"
      },
      {
        "id": "nci_5_1",
        "name": "Inclusion Criteria",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.1",
        "sectionTitle": "Inclusion Criteria"
      },
      {
        "id": "nci_5_2",
        "name": "Exclusion Criteria",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.2",
        "sectionTitle": "Exclusion Criteria"
      },
      {
        "id": "nci_5_3",
        "name": "Lifestyle Considerations",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.3",
        "sectionTitle": "Lifestyle Considerations"
      },
      {
        "id": "nci_5_4",
        "name": "Screen Failures",
        "text": "",
        "order": 3,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.4",
        "sectionTitle": "Screen Failures"
      },
      {
        "id": "nci_10_1",
        "name": "Definition of AE",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "10.3.1",
        "sectionTitle": "Definition of AE"
      },
      {
        "id": "nci_10_2",
        "name": "Definition of SAE",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "10.3.2",
        "sectionTitle": "Definition of SAE"
      },
      {
        "id": "nci_10_3",
        "name": "Recording and Follow-Up of AE and/or SAE",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "10.3.3",
        "sectionTitle": "Recording and Follow-Up of AE and/or SAE"
      },
      {
        "id": "nci_10_4",
        "name": "Reporting of SAEs",
        "text": "",
        "order": 3,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "10.3.4",
        "sectionTitle": "Reporting of SAEs"
      },
      {
        "id": "nci_11_1",
        "name": "Definitions and Contraceptive Guidance",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "10.4.1",
        "sectionTitle": "Definitions and Contraceptive Guidance"
      },
      {
        "id": "nci_11_2",
        "name": "Collection of Pregnancy Information",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "10.4.2",
        "sectionTitle": "Collection of Pregnancy Information"
      }
    ],
    "abbreviations": [
      {
        "id": "abbr_1",
        "abbreviatedText": "SoA",
        "expandedText": "Schedule of Activities",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_2",
        "abbreviatedText": "SARS-CoV-2",
        "expandedText": "Coronavirus",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_3",
        "abbreviatedText": "AE",
        "expandedText": "Adverse Event",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_4",
        "abbreviatedText": "SAE",
        "expandedText": "Serious Adverse Event",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_5",
        "abbreviatedText": "COVID-19",
        "expandedText": "Coronavirus (SARS-CoV-2) Disease 2019",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_6",
        "abbreviatedText": "WD",
        "expandedText": "Wilson disease",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_7",
        "abbreviatedText": "ADME",
        "expandedText": "absorption, distribution, metabolism, and excretion",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_8",
        "abbreviatedText": "PK",
        "expandedText": "plasma pharmacokinetics",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_9",
        "abbreviatedText": "NCC",
        "expandedText": "non-ceruloplasmin-bound copper",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_10",
        "abbreviatedText": "NCCcorrected",
        "expandedText": "non-ceruloplasmin-bound copper corrected",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_11",
        "abbreviatedText": "TPC",
        "expandedText": "tetrathiomolybdate- copper -albumin tripartite complex",
        "instanceType": "Abbreviation"
      }
    ],
    "summary": {
      "sectionCount": 15,
      "itemCount": 20,
      "abbreviationCount": 11
    },
    "studyDefinitionDocument": {
      "id": "sdd_1",
      "name": "A Phase 2, Open-label Study to Assess Copper and Molybdenum Balance in Participants with Wilson Disease Treated with ALXN1840",
      "documentType": "Protocol",
      "language": "en",
      "instanceType": "StudyDefinitionDocument",
      "version": "3.1",
      "versionDate": "2022-03-18",
      "contentIds": [
        "nc_1",
        "nc_2",
        "nc_3",
        "nc_4",
        "nc_5",
        "nc_6",
        "nc_7",
        "nc_8",
        "nc_9",
        "nc_10",
        "nc_11",
        "nc_12",
        "nc_13",
        "nc_14",
        "nc_15"
      ]
    }
  },
  "rawResponse": {
    "abbreviations": {
      "abbreviations": [
        {
          "abbreviation": "SoA",
          "expansion": "Schedule of Activities"
        },
        {
          "abbreviation": "SARS-CoV-2",
          "expansion": "Coronavirus"
        },
        {
          "abbreviation": "AE",
          "expansion": "Adverse Event"
        },
        {
          "abbreviation": "SAE",
          "expansion": "Serious Adverse Event"
        },
        {
          "abbreviation": "COVID-19",
          "expansion": "Coronavirus (SARS-CoV-2) Disease 2019"
        },
        {
          "abbreviation": "WD",
          "expansion": "Wilson disease"
        },
        {
          "abbreviation": "ADME",
          "expansion": "absorption, distribution, metabolism, and excretion"
        },
        {
          "abbreviation": "PK",
          "expansion": "plasma pharmacokinetics"
        },
        {
          "abbreviation": "NCC",
          "expansion": "non-ceruloplasmin-bound copper"
        },
        {
          "abbreviation": "NCCcorrected",
          "expansion": "non-ceruloplasmin-bound copper corrected"
        },
        {
          "abbreviation": "TPC",
          "expansion": "tetrathiomolybdate- copper -albumin tripartite complex"
        }
      ]
    },
    "structure": {
      "document": {
        "title": "A Phase 2, Open-label Study to Assess Copper and Molybdenum Balance in Participants with Wilson Disease Treated with ALXN1840",
        "version": "3.1",
        "versionDate": "2022-03-18"
      },
      "sections": [
        {
          "number": "1",
          "title": "PROTOCOL SUMMARY",
          "type": "Synopsis",
          "subsections": [
            {
              "number": "1.1",
              "title": "Synopsis",
              "type": "Synopsis"
            },
            {
              "number": "1.2",
              "title": "Schema",
              "type": "Study Design"
            },
            {
              "number": "1.3",
              "title": "Schedule of Activities (SoA)",
              "type": "Assessments"
            }
          ]
        },
        {
          "number": "2",
          "title": "INTRODUCTION",
          "type": "Introduction",
          "subsections": [
            {
              "number": "2.1",
              "title": "Study Rationale",
              "type": "Introduction"
            },
            {
              "number": "2.2",
              "title": "Background",
              "type": "Introduction"
            },
            {
              "number": "2.3",
              "title": "Benefit-Risk Assessment",
              "type": "Safety",
              "subsections": [
                {
                  "number": "2.3.1",
                  "title": "Risk Assessment",
                  "type": "Safety",
                  "subsections": [
                    {
                      "number": "2.3.1.1",
                      "title": "Coronavirus (SARS-CoV-2) Disease 2019",
                      "type": "Safety"
                    }
                  ]
                },
                {
                  "number": "2.3.2",
                  "title": "Benefit Assessment",
                  "type": "Safety"
                },
                {
                  "number": "2.3.3",
                  "title": "Overall Benefit-Risk Conclusion",
                  "type": "Safety"
                }
              ]
            }
          ]
        },
        {
          "number": "3",
          "title": "OBJECTIVES AND ENDPOINTS",
          "type": "Objectives"
        },
        {
          "number": "4",
          "title": "STUDY DESIGN",
          "type": "Study Design",
          "subsections": [
            {
              "number": "4.1",
              "title": "Overall Design",
              "type": "Study Design"
            },
            {
              "number": "4.2",
              "title": "Scientific Rationale for Study Design",
              "type": "Study Design",
              "subsections": [
                {
                  "number": "4.2.1",
                  "title": "Participant Input into Design",
                  "type": "Study Design"
                }
              ]
            },
            {
              "number": "4.3",
              "title": "Justification for Dose",
              "type": "Study Design"
            },
            {
              "number": "4.4",
              "title": "End of Study Definition",
              "type": "Study Design"
            }
          ]
        },
        {
          "number": "5",
          "title": "STUDY POPULATION",
          "type": "Study Population",
          "subsections": [
            {
              "number": "5.1",
              "title": "Inclusion Criteria",
              "type": "Eligibility Criteria"
            },
            {
              "number": "5.2",
              "title": "Exclusion Criteria",
              "type": "Eligibility Criteria"
            },
            {
              "number": "5.3",
              "title": "Lifestyle Considerations",
              "type": "Eligibility Criteria"
            },
            {
              "number": "5.4",
              "title": "Screen Failures",
              "type": "Study Population"
            }
          ]
        },
        {
          "number": "6",
          "title": "STUDY INTERVENTION",
          "type": "Treatment"
        },
        {
          "number": "10.1.8",
          "title": "Study and Site Start and Closure",
          "type": "Other"
        },
        {
          "number": "10.1.9",
          "title": "Publication Policy",
          "type": "Ethics"
        },
        {
          "number": "10.2",
          "title": "Clinical Laboratory Tests",
          "type": "Assessments"
        },
        {
          "number": "10.3",
          "title": "Adverse Events: Definitions and Procedures for Recording, Evaluating, Follow-up, and Reporting",
          "type": "Safety",
          "subsections": [
            {
              "number": "10.3.1",
              "title": "Definition of AE",
              "type": "Safety"
            },
            {
              "number": "10.3.2",
              "title": "Definition of SAE",
              "type": "Safety"
            },
            {
              "number": "10.3.3",
              "title": "Recording and Follow-Up of AE and/or SAE",
              "type": "Safety"
            },
            {
              "number": "10.3.4",
              "title": "Reporting of SAEs",
              "type": "Safety"
            }
          ]
        },
        {
          "number": "10.4",
          "title": "Contraceptive Guidance and Collection of Pregnancy Information",
          "type": "Safety",
          "subsections": [
            {
              "number": "10.4.1",
              "title": "Definitions and Contraceptive Guidance",
              "type": "Safety"
            },
            {
              "number": "10.4.2",
              "title": "Collection of Pregnancy Information",
              "type": "Safety"
            }
          ]
        },
        {
          "number": "10.5",
          "title": "COVID-19 Vaccine Risk Assessment",
          "type": "Safety"
        },
        {
          "number": "10.6",
          "title": "Abbreviations",
          "type": "Appendix"
        },
        {
          "number": "10.7",
          "title": "Protocol Amendment History",
          "type": "Other"
        },
        {
          "number": "11",
          "title": "REFERENCES",
          "type": "References"
        }
      ]
    }
  }
}